Cargando…
Marked Increase in Sales of Erectile Dysfunction Medication During COVID-19
Autores principales: | Hernandez, Inmaculada, Gul, Zeynep, Gellad, Walid F., Davies, Benjamin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229258/ https://www.ncbi.nlm.nih.gov/pubmed/34170453 http://dx.doi.org/10.1007/s11606-021-06968-2 |
Ejemplares similares
-
Buprenorphine Dispensing in Pennsylvania During the COVID-19 Pandemic, January to October 2020
por: Chalasani, Rohan, et al.
Publicado: (2021) -
Increased number of cases of giant cell arteritis and higher rates of ophthalmic involvement during the era of COVID-19
por: Luther, Rosamond, et al.
Publicado: (2020) -
Continued increases in the incidence of healthcare-associated infection (HAI) during the second year of the coronavirus disease 2019 (COVID-19) pandemic
por: Lastinger, Lindsey M., et al.
Publicado: (2022) -
Interpreting COVID-19 Test Results: a Bayesian Approach
por: Good, Chester B., et al.
Publicado: (2020) -
Markers of erectile dysfunction
por: Davies, Kelvin P., et al.
Publicado: (2008)